Adult-onset Still's disease with neurological involvement: a single-centre report

被引:14
作者
Zhao, Mengzhu [1 ]
Wu, Di [1 ]
Shen, Min [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp,Minist Educ, Natl Clin Res Ctr Dermatol & Immunol Dis, Dept Rheumatol,Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
adult-onset Still's disease; AOSD; nervous system; aseptic meningitis; macrophage activation syndrome; NERVOUS-SYSTEM INVOLVEMENT; ASEPTIC-MENINGITIS; PATIENT;
D O I
10.1093/rheumatology/keaa899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Adult-onset Still's disease (AOSD) is a multifactorial systemic autoinflammatory disease. Neurological damage has been rarely reported in AOSD. We aimed to characterize the clinical features of AOSD patients with neurological involvement. Methods A total of 187 AOSD patients were admitted to Peking Union Medical College Hospital from January 2015 to August 2019. The complete medical records were reviewed in this retrospective study. Clinical features of 14 AOSD patients with neurological involvement were collected and compared with those without. Results The prevalence of neurological involvement in AOSD inpatients was 7.5%. The median disease duration was 4.5months, with a range of 1-15months. The frequent symptoms were fever [14 (100%)], rash [13 (92.9%)], liver dysfunction [11 (78.6%)], arthralgia/arthritis [10 (71.4%)] and lymphadenopathy [10 (71.4%)]. Four (28.6%) patients had macrophage activation syndrome (MAS). Aseptic meningitis was the most common presentation (64.3%) when the nervous system was involved. Other rare manifestations included cranial nerve palsy, encephalitis and cerebral infarction. The rate of MAS, serum levels of lactate dehydrogenase and ferritin were significantly higher in AOSD patients with neurological involvement than in those without. All patients received high-dose corticosteroid therapy and immunosuppressive agents and two were given tocilizumab. Clinical remission was achieved in all 14 AOSD patients with neurological involvement. Conclusion Neurological involvement, particularly aseptic meningitis, is not a rare complication of AOSD. It is frequently complicated by MAS. There may be a potential relationship between the neurological damage of AOSD and MAS.
引用
收藏
页码:4152 / 4157
页数:6
相关论文
共 29 条
[1]   Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease Clinical Features, Predictive Factors, and Prognosis in 21 Patients [J].
Bae, Chang-Bum ;
Jung, Ju-Yang ;
Kim, Hyoun-Ah ;
Suh, Chang-Hee .
MEDICINE, 2015, 94 (04)
[2]   Still's disease can cause neutrophilic meningitis [J].
Blockmans, DE ;
Knockaert, DC ;
Bobbaers, HJ .
NEUROLOGY, 2000, 54 (05) :1203-1205
[3]   Autoimmune meningitis and encephalitis in adult-onset still disease - Case report [J].
Bozek, Milena ;
Konopko, Magdalena ;
Wierzba-Bobrowicz, Teresa ;
Witkowski, Grzegorz ;
Makowicz, Grzegorz ;
Sienkiewicz-Jarosz, Halina .
NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2017, 51 (05) :421-426
[4]   Adult-onset Still's disease: Advances in the treatment [J].
Castaneda, Santos ;
Blanco, Ricardo ;
Gonzalez-Gay, Miguel A. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (02) :222-238
[5]   Miller Fisher syndrome in adult onset Still's disease: case report and review of the literature of other neurological manifestations [J].
Desai, SS ;
Allen, E ;
Deodhar, A .
RHEUMATOLOGY, 2002, 41 (02) :216-222
[6]   Life-threatening complications of adult-onset Still's disease [J].
Efthimiou, Petros ;
Kadavath, Sabeeda ;
Mehta, Bella .
CLINICAL RHEUMATOLOGY, 2014, 33 (03) :305-314
[7]  
GARROTE FJ, 1993, J RHEUMATOL, V20, P765
[8]   Adult-onset Still's disease [J].
Gerfaud-Valentin, Mathieu ;
Jamilloux, Yvan ;
Iwaz, Jean ;
Seve, Pascal .
AUTOIMMUNITY REVIEWS, 2014, 13 (07) :708-722
[9]   Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review [J].
Gilboa, Mayan ;
Bornstein, Gil ;
Ben-Zvi, Ilan ;
Grossman, Chagai .
RHEUMATOLOGY INTERNATIONAL, 2020, 40 (04) :663-669
[10]  
Gopalarathinam R., 2016, CASE REP RHEUMATOL, V2016, P1, DOI 10.1155/2016/6502373